Protecting Trade Secrets During a Federal Lab Collaboration
A collaboration with a federal laboratory can provide access to specialized facilities, scientific expertise, and publicly funded research that would be difficult to reproduce independently. It can also create valuable commercial opportunities for companies developing advanced materials, medical devices, cybersecurity tools, energy systems, or other dual-use technologies.
The commercial value of that relationship depends partly on how well confidential business information is protected. A lab may need access to manufacturing methods, source code, test data, customer requirements, or unpublished research plans. Sharing that information without clear controls can weaken trade secret rights, complicate patent strategy, or expose a company to avoidable competitive risk.
Trade secret protection is based on reasonable efforts to keep valuable information secret. A nondisclosure agreement is important, but it is only one part of a broader information security and collaboration plan. Effective protection begins before the first technical meeting and continues through testing, publication review, records retention, and project closeout.
Identify What Must Remain Confidential
The first step is to distinguish genuine trade secrets from information that is already public, easily discoverable, or protected through another legal mechanism. A trade secret may include a formula, process, algorithm, design tolerance, experimental result, supplier arrangement, pricing model, or commercialization plan. The information must have economic value because it is not generally known, and the owner must take reasonable measures to preserve its secrecy.
Create a written inventory before discussions begin. Classify information by sensitivity, such as public, internal, confidential, restricted, or highly restricted. The inventory should identify the owner, business value, permitted recipients, approved storage location, retention period, and consequences of unauthorized disclosure. This record helps a company explain what it expected collaborators to protect.
Avoid marking every document “confidential” without further guidance. Overbroad labels can create confusion about what a laboratory may use, disclose, publish, or combine with government research. More precise markings, file permissions, and handling instructions make it easier for project personnel to follow the intended rules.
Establish Ownership Before Technical Work Starts
A collaboration agreement should address ownership of background information, newly created results, improvements, inventions, software, biological materials, and physical samples. Background intellectual property is information or technology that a party brings to the project. New project results may be developed by one party, jointly, or by a party using the other’s resources. These categories should not be left to informal understandings.
Federal technology transfer arrangements can involve facility-use agreements, cooperative research and development agreements, licensing terms, material transfer agreements, or other instruments. Each may contain different provisions concerning confidential information, inventions, government rights, publication, records, and access to research results. Legal and technology transfer personnel should review the agreement together rather than treating confidentiality as a separate administrative detail.
Pay close attention to residual knowledge clauses, independent development language, and rights to use generalized skills or experience. A provision allowing personnel to retain general know-how may be reasonable, but it should not permit the reconstruction or reuse of a specific secret process. The agreement should also explain how independently developed results will be documented and separated from confidential project information.
For companies exploring federally developed technologies, the dual-use technology examples illustrate why ownership and permitted-use terms deserve careful attention. A technology originally developed for government purposes may have commercial applications, yet the path from laboratory research to market can involve several layers of intellectual property and disclosure obligations.
Match Safeguards to the Information
A practical protection program combines contractual, technical, physical, and organizational safeguards. The right level of protection depends on the sensitivity of the information, the number of people who need access, the collaboration’s duration, and the consequences of disclosure. A small project team can often use simple controls effectively if responsibilities are clear and consistently followed.
| Protection area | Useful control | Common failure to avoid |
|---|---|---|
| Contractual | Mutual confidentiality terms, permitted-use limits, return or destruction duties | Relying on a generic NDA that ignores publication and government-record rules |
| Technical | Access controls, encryption, secure file exchange, audit logs | Sending restricted files through personal email or unapproved cloud storage |
| Physical | Visitor controls, locked cabinets, clean-desk practices, sample tracking | Leaving notebooks, prototypes, or test specimens unattended |
| Organizational | Training, confidentiality contacts, access approvals, exit procedures | Giving every collaborator broad access for convenience |
| Documentation | Version control, disclosure registers, invention records, meeting summaries | Failing to record what was shared and when |
Digital safeguards should reflect the actual workflow. If a federal laboratory and a company use different systems, agree in advance on an approved method for exchanging files. Confirm who can download, copy, modify, or forward materials. Use unique accounts rather than shared credentials, and remove access promptly when someone changes roles or leaves the project.
Physical materials require similar discipline. Label prototypes, samples, notebooks, and instrument outputs with an identifier tied to the information inventory. Maintain chain-of-custody records when materials move between facilities. If a sample contains a proprietary formulation, the receiving party should know whether it may characterize, modify, retain, reproduce, or transfer that sample.
Limit Disclosure During Collaboration
Confidentiality is easier to preserve when disclosure follows a need-to-know model. Before a meeting, identify the specific decision or experiment that requires sensitive information. Share the minimum technical detail needed to accomplish that purpose, and use sanitized examples when exact figures, source code, or process parameters are unnecessary.
Create a participant list for each project phase. It should include employees, federal researchers, contractors, students, consultants, visitors, and subcontractors who may receive restricted information. Verify that each person is covered by an appropriate confidentiality obligation and understands the project’s handling rules. A person’s affiliation with a trusted organization does not automatically establish the necessary legal or operational protections.
Meeting practices matter. Use agendas that identify confidential topics, begin with a brief handling reminder, and record attendance. Mark minutes according to the sensitivity of their contents. If a discussion moves into material that is outside the approved scope, pause and determine whether an amendment or additional authorization is required.
Project teams should also separate technical collaboration from commercial disclosure. A laboratory may need to understand how a product works without receiving customer lists, pricing strategy, supplier terms, or the company’s full manufacturing roadmap. Segmenting information reduces exposure and allows the scientific work to proceed without unnecessarily revealing the company’s broader competitive position.
Coordinate Trade Secrets With Publication and Patent Rights
Federal research environments often value openness, peer review, reports, presentations, and scientific publication. Companies may need time to preserve trade secret status, file a patent application, or evaluate whether a result has commercial value. These interests can coexist when the agreement provides a workable review process.
A publication-review clause should establish who reviews manuscripts, posters, conference abstracts, websites, press releases, data releases, and public demonstrations. It should specify a defined review period, the types of changes that may be requested, and the process for removing confidential information. A company may reasonably request deletion of its trade secrets or a short delay to pursue patent protection, but an unlimited veto over legitimate government research publication may be impractical.
Keep trade secrets and patentable inventions under active review. Patent rights generally depend on timely filing and can be damaged by premature public disclosure. Trade secret rights depend on continued secrecy and may be lost if information enters the public domain. A project decision tree should identify when counsel, a patent professional, or a technology transfer office must be consulted.
Maintain contemporaneous records of creation and disclosure. Laboratory notebooks, version histories, dated design files, experiment records, and invention disclosures can help establish who developed an idea, when a secret was shared, and which controls applied. Accurate records also support disputes over ownership or alleged misuse.
Make Security Responsibilities Routine
Written policies are most effective when they translate into repeatable behavior. Every person with access should know how to identify restricted information, where to store it, whom to contact before sharing it, and what to do after a suspected incident. Short project-specific training is often more useful than a general annual course that does not address the collaboration’s actual risks.
Use the following safeguards as a baseline for a joint laboratory project:
- Name a confidentiality lead for each participating organization and establish a prompt escalation route.
- Create a shared information classification and marking system before exchanging technical material.
- Approve collaboration tools, storage locations, removable media, and methods for transferring physical samples.
- Review access at project milestones and revoke permissions when personnel or responsibilities change.
- Conduct a closeout review covering retained files, returned materials, publication plans, and continuing obligations.
Incident response should be agreed upon before an incident occurs. The plan should define what counts as a suspected disclosure, how quickly the parties must notify one another, who preserves evidence, and who communicates with affected customers, regulators, insurers, or law enforcement. Prompt containment can protect both the information and the credibility of the collaboration.
A closeout process is equally important. Collect or destroy copies when required, confirm that backups and shared folders have been addressed, document any authorized retention, and remind personnel that confidentiality duties may continue after the project ends. Continuing obligations should be clear enough to apply to archived data, derived results, and information remembered by former project members.
Build Confidence Through Documented Collaboration
Successful lab partnerships are built on scientific openness within a controlled boundary. Companies should be willing to share the information required for meaningful technical work, while laboratories and research partners should receive clear instructions about what may be used, disclosed, published, or retained. That balance protects innovation without turning every conversation into an obstacle.
Before signing an agreement or sending proprietary materials, map the information flow from first contact through project closeout. Identify each recipient, system, facility, document type, sample, and publication decision. Then compare that map with the proposed contract and revise any gap with help from counsel and the relevant technology transfer office.
Federal laboratories and the broader technology transfer network can help organizations locate expertise and evaluate commercialization pathways. Companies that prepare a disciplined confidentiality framework in advance are better positioned to explore those opportunities while preserving valuable know-how.
Begin with an inventory, a tailored agreement, and a short meeting with the laboratory’s technology transfer and security contacts. With those foundations in place, your organization can share strategically, document ownership, and move promising research toward a commercial partnership without surrendering control of its most valuable secrets.